GC Aesthetics, one of the largest independent aesthetic companies globally, has raised $40 million of financing from new investor OrbiMed, alongside nearly $20M from existing investors including Montreux Equity Partners and Oyster Capital. This financing will fuel further international expansion, new product development and launches. It will continue to support GC Aesthetics' vision to become the world's leading independent medical aesthetics company.

GC Aesthetics is a global leader in the aesthetic and plastic surgery market with their flagship brands: UK-based Nagor and France-based Eurosilicone. GC Aesthetics has had manufacturing plants in Europe for over 30 years, and plans further expansion of its operations in Europe to meet the growing demand. The company, whose products sell in over 90 countries, has been growing their business worldwide with a new executive team at the helm since the beginning of 2013.

Ayse Kocak, CEO of GC Aesthetics and the industry's first-ever female CEO says: 'We are delighted to have secured this funding that will allow GC Aesthetics consolidate its position as a market leader in aesthetics, and one which continues to keep women's interests at the forefront of all our goals. This has been an exciting year for us and we have laid the foundations to launch groundbreaking initiatives. This funding will enable us to maximize further growth, introduce our quality products to new markets and give patients and surgeons more choice than ever before'.

Daniel K. Turner III, Managing Director of Montreux Equity Partners and Chairman of GC Aesthetics, added, 'Ayse and the GC Aesthetics management team are transforming the aesthetics market with their focus on the health and wellness of women. Our continued financial commitment demonstrates our excitement for GC Aesthetics growth prospects as it becomes a global market leader in aesthetics.'